Author

Allyson Berent

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Andrew HillhouseiD· 1 shared Annalise SchlaferiD· 1 shared Anne E. AndersoniD· 1 shared Baraa Abudiab· 1 shared David Jay SegaliD· 1 shared Edwin J. WeeberiD· 1 shared Hillary ShaheeniD· 1 shared Jennifer PanagouliasiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Andrew HillhouseORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neuron-Specific WWOX Gene Therapy Produces Dose-Dependent, Durable Rescue in a Model of WWOX-Related Epileptic Encephalopathy

Mustafa Obeid, Rania Akkawi, Srinivasarao Repudi, Prince Kumar Singh, Baraa Abudiab, Takwa Jebara, Allyson Berent, Thomas Brennan, Yael Weiss, Tawfeeq Shekh‐Ahmad, Rami I. Aqeilan

This study identifies optimal parameters for neuron-targeted WWOX gene therapy in a mouse model of WWOX-related epileptic encephalopathy, showing durable rescue with a defined therapeutic window and dose.

Molecular Therapy Advances · Jun 19, 2026Peer-reviewedNeuroscience

Development of an ASO therapy for Angelman syndrome by targeting an evolutionarily conserved region at the start of the UBE3A-AS transcript

Scott V. Dindot, Sarah Christian, William J. Murphy, Allyson Berent, Jennifer Panagoulias, Annalise Schlafer, Johnathan L. Ballard, Kamelia Radeva, Ruth Robinson, Luke S. Myers, Thomas Jepp, Hillary Shaheen, Paul Hillman, Kranti Konganti, Andrew Hillhouse, , Jill L. Silverman

This paper describes the development of an antisense oligonucleotide (ASO) therapy targeting the UBE3A-AS transcript to reactivate paternal UBE3A expression in Angelman syndrome models.

Science Translational Medicine · Mar 22, 2023Peer-reviewedGenetics